Skip to main content

About Us

OUR VISION

HISTORY

Opening the future of healthcare with cutting-edge AI technology.

SHMD contributes to the advancement of the medical industry through AI-based blood flow diagnostic technology.

History

2025

  • Now

    Series A funding round

  • 05

    Developed CEREBAND prototype

  • 05

    Launched BRAINCHECK.AI

  • 04

    Selected by Chungbuk Intellectual Property Center’s IP Narae program

  • 04

    Selected as a potential export company of Korea.

  • 02

    Awarded the 2025 Korea Industry Grand Prize

2024

  • 12

    Selected for TIPS R&D program

  • 10

    Nationwide Clinical Trial for BRAINCHECK AI tool

  • 10

    Secured Angel Investment

  • 07

    Selected for Startup-NEST by Korea Credit Guarantee Fund

  • 06

    Established SHMD.LTD

VISION

Opening a new era of predicting and preventing vascular
diseases with non-invasive AI technology.

SHMD protects vascular health through AI-powered non-invasive diagnostics.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.